Myriad Genetics
MYGN
#7319
Rank
โ‚น48.52 B
Marketcap
โ‚น505.92
Share price
-1.44%
Change (1 day)
-11.42%
Change (1 year)

EPS for Myriad Genetics (MYGN)

EPS in 2026 (TTM): -โ‚น128.62

According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is -โ‚น126.02. In 2025 the company made an earnings per share (EPS) of -โ‚น365.08 a decrease over its 2024 EPS that were of -โ‚น130.65.

EPS history for Myriad Genetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น128.62-64.77%
2025-โ‚น365.08179.43%
2024-โ‚น130.65-55.94%
2023-โ‚น296.51130.22%
2022-โ‚น128.80275.68%
2021-โ‚น34.28-87.99%
2020-โ‚น285.39755.56%
2019-โ‚น33.36-194.74%
2018โ‚น35.21-79.89%
2017โ‚น175.13112.36%
2016โ‚น82.47-35.97%
2015โ‚น128.80-7.33%
2014โ‚น138.99-37.24%
2013โ‚น221.4659.33%
2012โ‚น138.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
โ‚น250.54-298.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-โ‚น492.95 291.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-โ‚น8.34-93.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚น4,716 3,642.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
โ‚น3,536-2,905.88%๐Ÿ‡บ๐Ÿ‡ธ USA